GoodRx Holdings Inc (NAS:GDRX)
$ 6.65 -0.05 (-0.75%) Market Cap: 2.50 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 3.98 GF Score: 80/100

Goodrx Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 10, 2021 / 06:00PM GMT
Release Date Price: $42.39 (+0.71%)
Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

Thank you for joining us today at Morgan Stanley's Global Healthcare Conference. I'm Ricky Goldwasser, Morgan Stanley's health care services analyst, and I'm really pleased to have with me here the GoodRx management team. We have Doug Hirsch, who's the co-CEO of GoodRx; and Karsten Voermann, who's CFO.

Before we get started, we need to do a few disclosures. So first of all, this webcast is only from Morgan Stanley clients and appropriate Morgan Stanley employees, and it's not for the members of the press. And for important disclosures, I'll just refer you to our research website at www.morganstanley.com/researchdisclosures.

And with that, I'll hand it over to Whitney on the GoodRx side to give some forward-looking statements.

Whitney Notaro
GoodRx Holdings, Inc. - VP of IR

Thanks so much for having us, Ricky. Before we begin, I just want to remind the audience that this webcast may contain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot